Skip to content

Efficacy Observation of Wound Care Ointment (Suile) on Incision Healing after Mixed Hemorrhoid Surgery

Efficacy Observation of Wound Care Ointment (Suile) on Incision Healing after Mixed Hemorrhoid Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600123181
Enrollment
Unknown
Registered
2026-04-22
Start date
2023-09-06
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Period of Mixed Hemorrhoid Surgery

Interventions

Trial Group:Routine iodophor dressing change after hemorrhoidectomy, followed by saline irrigation, application of Suyule soft ointment (approximately 1 cm thickness) on the incision site, covering wi
Control Group:Routine iodophor dressing change after hemorrhoidectomy (one layer of gauze bandage, followed by fixation with breathable adhesive tape, twice daily)

Sponsors

PengZhou People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Aged 18 years or older, gender not restricted; 2. Diagnosed with mixed hemorrhoids; 3.No underlying diseases that affect wound healing (such as diabetes), no severe diseases of major organs or blood system, and no contraindications to surgery; 4. No previous anal surgery history, no anorectal stenosis, and normal anal appearance, sensation, and fecal control function; 5. Voluntarily participate in this study, with complete and reliable medical history, able to complete re-examination and follow-up, and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Patients with other perianal diseases, such as anal fissure, anal fistula, perianal abscess, inflammatory bowel disease, and colorectal polyps; 2. Patients with scar constitution, multiple drug allergies, or a history of drug abuse; 3. Patients with other organ or system diseases, uncontrolled infection, intolerance or inappropriateness for surgery; 4. Female patients who are in menstruation, lactation, or pregnant; 5. Patients with anal margin scars or abnormal anal function; 6. Patients with long-term intractable constipation or diarrhea; 7. Patients with coagulation disorders; 8. Patients participating in other clinical studies simultaneously.

Design outcomes

Primary

MeasureTime frame
Incision healing time;Pain score;Bleeding score;Edema;Infection;Scar hyperplasia;

Countries

China

Contacts

Public ContactHe Baozhen

PengZhou People's Hospital

328969386@qq.com+86 28 8623 9889

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 9, 2026